Will Suzetrigine/VX-548 (non-opioid painkiller) be prescribed to >500k patients in 2025?
Plus
0
2026
50%
chance
1D
1W
1M
ALL
Vertex Pharmaceuticals has a new non-opioid pain medication called VX-548 (Suzetrigine); per https://news.vrtx.com/news-releases/news-release-details/vertex-announces-fda-acceptance-new-drug-application-suzetrigine they expect FDA action on their application in January.
In 2020, 12.7 million people were prescribed opioids in the US alone ( https://meps.ahrq.gov/data_files/publications/st552/stat552.shtml ); 500k would represent <5% of the market.
I learned about this medication through a person with inside information and therefore will not trade on this market.
Related market: https://manifold.markets/PGeyer/pain-relief-vs-addiction-will-verte
This question is managed and resolved by Manifold.
Get
1,000
and3.00
Related questions
Related questions
Pain Relief vs Addiction: Will Vertex’s non-opioid (hopefully nonaddictive) Suzetrigine/VX-548 be FDA-approved in 2024?
37% chance
Will Pfizer announce a weight loss drug competing with Ozempic and Wygovy before 12/31/2024?
35% chance
Will a drug to be used by most healthy adults be approved by 2043 year end?
66% chance
Will a senolytic drug be used clinically for any purpose by the end of 2028?
58% chance
Will fewer people use ketamine as an antidepressant in 2024 than in 2023?
39% chance
Will a Vyvanse generic be available in the UK in 2024?
71% chance
Will the FDA approve a drug to prevent migraine headaches by 2025?
66% chance
💊Will FDA approve 50 or more novel drugs in 2024?
84% chance
Will any country legalize recreational use of opioids before 2045?
57% chance
Will any country legalize recreational use of opioids before 2100?
69% chance